Literature DB >> 7651827

Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.

J K Chen1, R G Schultz, D H Lloyd, S M Gryaznov.   

Abstract

An efficient synthesis of the novel nucleic acid analogs oligodeoxyribonucleotide N3'-->P5' phosphoramidates, where the 3'-oxygen is substituted by a 3'-nitrogen, is described. Synthesis of the title compounds was accomplished by the following synthetic steps. First, 5'-O-DMT base-protected-3'-amino-2',3'-dideoxynucleosides were prepared. The 3'-aminopyrimidines were obtained via the corresponding 2,3'-anhydronucleosides, whereas 3'-aminopurines were derived via 2'-deoxyxylo precursors. Second, using the prepared 3'-aminonucleosides, oligonucleotide N3'-->P5' phosphoramidates were synthesized on a solid support. Oligonucleotide chain assembly was based upon a carbon tetrachloride-driven oxidative coupling of the appropriately protected 3'-aminonucleosides with the 5'-H-phosphonate diester group, resulting in the formation of an internucleoside phosphoramidate link. Fully deprotected oligonucleotide N3'-->P5' phosphoramidates were characterized by ion exchange and reversed phase HPLC, capillary and slab gel electrophoresis and by 31P NMR analysis. Oligonucleotide N3'-->P5' phosphoramidates form remarkably stable duplexes with complementary RNA strands and also with themselves, where the melting temperature of the complexes exceeded that for the parent phosphodiester compounds by 26-33 degrees C. Additionally, duplexes formed by oligonucleotide phosphoramidates with single-stranded DNA were also more thermally stable than those formed by phosphodiesters. The described properties indicate that these compounds may have great potential in oligonucleotide-based diagnostics and therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651827      PMCID: PMC307090          DOI: 10.1093/nar/23.14.2661

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  4 in total

1.  DNA hairpin loops in solution. Correlation between primary structure, thermostability and reactivity with single-strand-specific nuclease from mung bean.

Authors:  L E Xodo; G Manzini; F Quadrifoglio; G van der Marel; J van Boom
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

2.  Selective O-phosphitilation with nucleoside phosphoramidite reagents.

Authors:  S M Gryaznov; R L Letsinger
Journal:  Nucleic Acids Res       Date:  1992-04-25       Impact factor: 16.971

3.  DNA-RNA hybrid duplexes containing oligo(dA:rU) sequences are exceptionally unstable and may facilitate termination of transcription.

Authors:  F H Martin; I Tinoco
Journal:  Nucleic Acids Res       Date:  1980-05-24       Impact factor: 16.971

4.  Synthesis and properties of oligonucleotides containing aminodeoxythymidine units.

Authors:  S M Gryaznov; R L Letsinger
Journal:  Nucleic Acids Res       Date:  1992-07-11       Impact factor: 16.971

  4 in total
  19 in total

1.  Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.

Authors:  R G Schultz; S M Gryaznov
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

2.  RNase H-independent antisense activity of oligonucleotide N3 '--> P5 ' phosphoramidates.

Authors:  O Heidenreich; S Gryaznov; M Nerenberg
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

3.  alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.

Authors:  K Pongracz; S M Gryaznov
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

4.  Antileukemia effect of c-myc N3'-->P5' phosphoramidate antisense oligonucleotides in vivo.

Authors:  T Skorski; D Perrotti; M Nieborowska-Skorska; S Gryaznov; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.

Authors:  S Gryaznov; T Skorski; C Cucco; M Nieborowska-Skorska; C Y Chiu; D Lloyd; J K Chen; M Koziolkiewicz; B Calabretta
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

6.  RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.

Authors:  S M Gryaznov; H Winter
Journal:  Nucleic Acids Res       Date:  1998-09-15       Impact factor: 16.971

Review 7.  Crystallographic studies of chemically modified nucleic acids: a backward glance.

Authors:  Martin Egli; Pradeep S Pallan
Journal:  Chem Biodivers       Date:  2010-01       Impact factor: 2.408

8.  An improved synthesis of oligodeoxynucleotide N3'-->P5' phosphoramidates and their chimera using hindered phosphoramidite monomers and a novel handle for reverse phase purification.

Authors:  K L Fearon; B L Hirschbein; J S Nelson; M F Foy; M Q Nguyen; A Okruszek; S N McCurdy; J E Frediani; L A DeDionisio; A M Raible; E N Cagle; V Boyd
Journal:  Nucleic Acids Res       Date:  1998-08-15       Impact factor: 16.971

9.  Synthesis of nucleoside mono-, di-, and triphosphoramidates from solid-phase cyclosaligenyl phosphitylating reagents.

Authors:  Yousef Ahmadibeni; Rakesh K Tiwari; Gongqin Sun; Keykavous Parang
Journal:  Org Lett       Date:  2009-05-21       Impact factor: 6.005

10.  N2'-->p3' phosphoramidate glycerol nucleic acid as a potential alternative genetic system.

Authors:  Jesse J Chen; Xin Cai; Jack W Szostak
Journal:  J Am Chem Soc       Date:  2009-02-18       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.